These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 3310672)

  • 1. Antipsychotic effect of buprenorphine in schizophrenia.
    Schmauss C; Yassouridis A; Emrich HM
    Am J Psychiatry; 1987 Oct; 144(10):1340-2. PubMed ID: 3310672
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical experience with depot neuroleptic treatment].
    Waldmann KD; Neumann J
    Z Arztl Fortbild (Jena); 1984; 78(20):853-6. PubMed ID: 6523910
    [No Abstract]   [Full Text] [Related]  

  • 3. [Is there a special indication for fluphenazine in therapy refractory hallucinations?].
    Bechter K
    Nervenarzt; 1994 Nov; 65(11):798-801. PubMed ID: 7816159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of the synthetic analogue of methionine enkephalin FK 33-824 in schizophrenic patients. A double blind trial.
    Jungkunz G; Nedopil N; Rüther E
    Pharmacopsychiatry; 1984 May; 17(3):76-8. PubMed ID: 6739537
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indication of an antipsychotic action of the opiate antagonist naloxone.
    Emrich HM; Cording C; Pirée S; Kölling A; von Zerssen D; Herz A
    Pharmakopsychiatr Neuropsychopharmakol; 1977 Sep; 10(5):265-70. PubMed ID: 30101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Body dysmorphic disorder and psychosis. Case reports and discussion].
    Loréa N; Van Wijnendaele R
    Encephale; 2012 Feb; 38(1):37-41. PubMed ID: 22381722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early longitudinal course of acute-chronic and paranoid--undifferentiated schizophrenia subtypes and schizophreniform disorder.
    Marengo JT; Harrow M; Westermeyer JF
    J Abnorm Psychol; 1991 Nov; 100(4):600-3. PubMed ID: 1757674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of naloxone in chronic schizophrenia.
    Berger PA; Watson SJ; Akil H; Barchas JD
    Am J Psychiatry; 1981 Jul; 138(7):913-8. PubMed ID: 6266259
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of naloxone on schizophrenia: reduction in hallucinations in a subpopulation of subjects.
    Watson SJ; Berger PA; Akil H; Mills MJ; Barchas JD
    Science; 1978 Jul; 201(4350):73-6. PubMed ID: 351804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of untreated psychosis and time to treatment response for delusions and hallucinations.
    Gunduz-Bruce H; McMeniman M; Robinson DG; Woerner MG; Kane JM; Schooler NR; Lieberman JA
    Am J Psychiatry; 2005 Oct; 162(10):1966-9. PubMed ID: 16199847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Psychopathologic and cognitive investigations in schizophrenia].
    Farkas M
    Orv Hetil; 2009 Mar; 150(9):423-9. PubMed ID: 19228571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delusions and hallucinations in Alzheimer disease.
    Gill SS
    Arch Neurol; 2006 Apr; 63(4):627; author reply 627. PubMed ID: 16606786
    [No Abstract]   [Full Text] [Related]  

  • 13. (Des-tyrosine1)-gamma-endorphin in schizophrenia: clinical, biochemical, and hormonal aspects.
    Verhoeven WM; Westenberg HG; Gerritsen TW; van Praag HM; Thijssen JH; Schwarz F; van Ree JM; de Wied D
    Psychiatry Res; 1981 Dec; 5(3):293-309. PubMed ID: 7034028
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The schizophrenic mind.
    Begley S
    Newsweek; 2002 Mar; 139(10):44-51. PubMed ID: 11894588
    [No Abstract]   [Full Text] [Related]  

  • 15. Relief of chronic intractable hallucinosis in residual schizophrenia with oxazepam.
    Lewis R
    Am J Psychiatry; 1985 Jun; 142(6):785. PubMed ID: 4003612
    [No Abstract]   [Full Text] [Related]  

  • 16. The use of monoamine oxidase inhibitors in schizophrenia.
    Brenner R; Shopsin B
    Biol Psychiatry; 1980 Aug; 15(4):633-47. PubMed ID: 7397294
    [No Abstract]   [Full Text] [Related]  

  • 17. [Specifics of various forms of paranoia and paraphrenia].
    Rappard E
    Ann Med Psychol (Paris); 1993 Apr; 151(4):313-6. PubMed ID: 8285499
    [No Abstract]   [Full Text] [Related]  

  • 18. [French Society for Biological Psychiatry and Neuropsychopharmacology task force: Formal Consensus for the prescription of depot antipsychotics].
    Samalin L; Abbar M; Courtet P; Guillaume S; Lancrenon S; Llorca PM
    Encephale; 2013 Dec; 39 Suppl 4():189-203. PubMed ID: 24373464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diazepam in schizophrenia: a preliminary double-blind trial.
    Jimerson DC; van Kammen DP; Post RM; Docherty JP; Bunney WE
    Am J Psychiatry; 1982 Apr; 139(4):489-91. PubMed ID: 7039369
    [No Abstract]   [Full Text] [Related]  

  • 20. [Erotomania and Frégoli syndrome. A case report].
    Brüggemann BR; Werry C; Garlipp P; Pfefferer-Wolf H; Haltenhof H
    Nervenarzt; 2002 May; 73(5):475-7. PubMed ID: 12078029
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.